6.08亿美元出售中药资产,和黄医药能否“新年新气象”?

医药研究社
02 Jan

“辞旧迎新”时刻。来源|医药研究社2025年,和黄医药势必要更加聚焦了。新年第一天,和黄医药发布公告,宣布全资附属公司以总购买价约4.73亿美元出售金浦健服待售股份(占上海和黄药业35%的股权),与金浦健服股权投资管理订立金浦健服购股协议;以总购买价约1.35亿美元出售上海医药待售股份(占上海和黄药业10%的股权),与上海医药订立上海医药购股协议。而出售中药资产背后,和黄医药正着力抗体偶联药物(...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10